AQbD Symposium 2024
Impact of Q14/Q2 on LC Procedures

Analytical Quality by Design (AQbD) is a science and risk-based approach to analytical procedure development that “starts with the end in mind”.

The recently adopted quality guidelines Q14 and Q2(R2) leverage AQbD principles. What does that mean for the Pharma LC lab? We are joined by industry thought leaders for an engaging discussion that will encompass strategies and case studies.

Each session will feature a panel of forward thinking leaders on the topic who will present their recent work and participate in a round table discussion.

Learning Objectives

• Understand opportunities and barriers related to the implementation of Q14
• Learn about analytical development strategies for every phase of clinical development
• Explore case studies applying Q14 to today’s analytical challenges
• Engage with pharma industry thought leaders

Session 2: Applying Q14 to Today's Analytical Challenges
Wednesday, December 4, 2024 | Time: 10:00am ET | 3:00pm GMT | 4:00pm CET

With the introduction of Q14 and Q2(R2), companies started working on applying these guidance to challenging analytical methods. Using appropriate software, the analytical methods are developed and validated. Our panelists will discuss some of these analytical challenges and how to overcome them by implementing Q14 and updating towards Q2(R2) in their procedures and processes._1733370820726